187 related articles for article (PubMed ID: 11895493)
1. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.
Aishima SI; Taguchi KI; Sugimachi K; Shimada M; Sugimachi K; Tsuneyoshi M
Histopathology; 2002 Mar; 40(3):269-78. PubMed ID: 11895493
[TBL] [Abstract][Full Text] [Related]
2. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
Terada T; Nakanuma Y; Sirica AE
Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
[TBL] [Abstract][Full Text] [Related]
5. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
Radaeva S; Ferreira-Gonzalez A; Sirica AE
Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.
Chen Y; Ma L; He Q; Zhang S; Zhang C; Jia W
Biol Res; 2015 May; 48(1):26. PubMed ID: 25993985
[TBL] [Abstract][Full Text] [Related]
9. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
[TBL] [Abstract][Full Text] [Related]
10. [Expressions and clinical significances of c-met, c-erbB-2, COX-2, and IL-6 in the biliary tract cancers].
Joo HH; Song EY; Jin SH; Oh SH; Choi YK
Korean J Gastroenterol; 2007 Dec; 50(6):370-8. PubMed ID: 18159174
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.
Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Higashiyama S; Monden M; Matsuura N
Pathol Res Pract; 2001; 197(2):95-100. PubMed ID: 11261824
[TBL] [Abstract][Full Text] [Related]
12. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
[TBL] [Abstract][Full Text] [Related]
13. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
14. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
[TBL] [Abstract][Full Text] [Related]
16. [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].
Lee SW; Kang SB; Kim YS; Nam SW; Lee DS; Lee HK; Han SW
Korean J Gastroenterol; 2007 Mar; 49(3):152-7. PubMed ID: 18172343
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
18. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].
Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH
Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
